Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015)

Collegium Pharmaceutical's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $50.4 million for Q1 2015.

• In Q1 2015, Preferred Stock Liabilities changed N/A year-over-year to $50.4 million; the TTM figure through Mar 2015 stood at $50.4 million (changed N/A YoY), while the FY2014 annual figure was $51.2 million, up 3.72% from the prior year.
• Preferred Stock Liabilities was $50.4 million for Q1 2015 at Collegium Pharmaceutical, down from $51.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $51.2 million in Q4 2014 to a low of $50.4 million in Q1 2015.